Información del producto
- 1H-Pyrido[4,3-b]indole, 2,3,4,5-tetrahydro-2-methyl-5-(phenylmethyl)-
- 1H-Pyrido[4,3-b]indole, 5-benzyl-2,3,4,5-tetrahydro-2-methyl-
- 2,3,4,5-Tetrahydro-2-methyl-5-(phenylmethyl)-1H-pyrido[4,3-b]indole
- 2H-Pyrido[4,3-b]indole, 5-benzyl-1,3,4,5-tetrahydro-2-methyl-
- 3-Methyl-9-benzyl-1,2,3,4-tetrahydro-γ-carboline
- 5-Benzyl-1,2,3,4-Tetrahydro-2-Methylpyrido(4,3-B)Indole
- 5-Benzyl-1,2,3,4-tetrahydro-2-methyl-γ-carboline
- 5-Benzyl-1,3,4,5-tetrahydro-2-methyl-2H-pyrido[4,3-b]indole
- 5-benzyl-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-2-ium
- 5-benzyl-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
- Ver más sinónimos
- N-Methyl-9-benzyltetrahydro-γ-carboline
- naphthalene-1,5-disulfonic acid - 5-benzyl-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole (1:1)
Mebhydrolin is a drug used to treat metabolic disorders and symptoms such as hyperglycemia, hyperlipidemia, and hyperuricemia. It is also used for the treatment of autoimmune diseases, such as rheumatoid arthritis. Mebhydrolin inhibits potassium dichromate-induced dopamine release in rat brain synaptosomes. The clinical relevance of this effect is not clear. Mebhydrolin has been shown to have no toxicological effects on the bowel and may be beneficial in bowel disease because it stimulates sodium citrate absorption. In addition, mebhydrolin has been shown to inhibit inflammatory bowel disease by blocking the 5HT3 receptor activity in animal studies.
Propiedades químicas
Consulta técnica sobre: 3D-AAA52481 Mebhydrolin
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.